Results 21 to 30 of about 55,357 (300)

The efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis: a systematic review and meta-analysis

open access: yesJournal of International Medical Research, 2020
Objective A systematic review and meta-analysis was carried out to evaluate the efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis. Methods The EMBASE and MEDLINE databases were searched to identify randomized controlled trials (
Shuchao Zhai, Botao Huang, Kai Yu
doaj   +1 more source

The binding of botulinum neurotoxins to different peripheral neurons [PDF]

open access: yes, 2017
Botulinum neurotoxins are the most potent toxins known. The double receptor binding modality represents one of the most significant properties of botulinum neurotoxins and largely accounts for their incredible potency and lethality.
Rossetto, O.
core   +1 more source

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]

open access: yes, 2011
Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Alexander Buchner   +20 more
core   +1 more source

Intra-sphincteric botulinum toxin in the management of functional biliary pain

open access: yesEndoscopy International Open, 2022
Background and study aims The management of functional biliary-type pain remains a clinical challenge. Intra sphincteric botulinum toxin putatively exerts an anti-spasmodic and anti-nociceptive effect.
Shyam Menon, Andrew Holt, Adam D. Farmer
doaj   +1 more source

Diagnostic nerve block in prediction of outcome of botulinum toxin treatment for spastic equinovarus foot after stroke: A retrospective observational study

open access: yesJournal of Rehabilitation Medicine, 2020
Objective: To evaluate the role of diagnostic nerve block in predicting the outcome of subsequent botulinum toxin type A treatment for spastic equinovarus foot due to chronic stroke. Design: Retrospective observational study.
Alessandro Picelli   +6 more
doaj   +1 more source

The impact of SARS-Cov-2 infection on the periocular injection pain and hypersensitive reaction to botulinum toxin type A: results from clinical questionnaires

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
BackgroundThe COVID-19 pandemic has brought about significant changes in the medical field, yet the use of botulinum toxin type A has remained uninterrupted.
Xiangyu Liu   +7 more
doaj   +1 more source

Safety and patient satisfaction of abobotulinumtoxinA for aesthetic use. A systematic review [PDF]

open access: yes, 2017
A systematic review of the published literature (from January 2000 to January 2016) to ascertain the safety of, and patient satisfaction with, the aesthetic use of abobotulinumtoxinA was conducted.
Cohen, Joel L, Scuderi, Nicolo'
core   +1 more source

Botulinum Toxin Type A With Oral Baclofen Versus Oral Tizanidine: A Nonrandomized Pilot Comparison in Patients With Cerebral Palsy and Spastic Equinus Foot Deformity [PDF]

open access: yes, 2008
The objective Of this Study was to compare the effectiveness of baclofen versus tizanidine as adjuvant treatment of botulinum toxin type A botulinum toxin type A in the management of children with spasticity. Thirty children with gastroenemius spasticity
Awan, Safia   +2 more
core   +2 more sources

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study [PDF]

open access: yes, 2017
To evaluate the role of botulinum toxin type A (BTX-A) in the treatment of pain associated with nocturnal bruxism. Fifty subjects reporting nocturnal bruxism were recruited for a randomized clinical trial. Twenty five bruxers were injected with botulinum
Al Wayli, Hessa
core   +1 more source

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder

open access: yesIJU Case Reports, 2022
Introduction We report a case of deterioration of bladder compliance after botulinum toxin type A injection and discontinuation of medication for overactive bladder.
Naoki Wada   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy